Table 2.
30-day mortality at various level of qSOFA, SIRS, NEWS, qSIRS and NSIRS of 1253 patients.
| Survived (n = 1182) | 30-day mortality (n = 71) | |||
|---|---|---|---|---|
| qSOFA | 923 | (95.8%) | 40 | (4.2%) |
| 0 | 211 | (91.7%) | 19 | (8.3%) |
| 1 | 10 | (55.6%) | 8 | (44.4%) |
| 2 | 0 | (90.5%) | 4 | (9.5%) |
| Missing data | ||||
| SIRS | ||||
| 0 | 490 | (97.4%) | 13 | (2.6%) |
| 1 | 379 | (94.5%) | 22 | (5.5%) |
| 2 | 168 | (90.8%) | 17 | (9.2%) |
| 3 | 65 | (89.0%) | 8 | (11.0%) |
| 4 | 15 | (83.3%) | 3 | (16.7%) |
| Missing data | 65 | (89.0%) | 8 | (11.0%) |
| NEWS | ||||
| 0 | 357 | (97.5%) | 9 | (2.5%) |
| 1 | 251 | (96.9%) | 8 | (3.1%) |
| 2 | 157 | (94.6%) | 9 | (5.4%) |
| 3 | 132 | (95.0%) | 7 | (5.0%) |
| 4 | 94 | (90.4%) | 10 | (9.6%) |
| 5 | 58 | (93.5%) | 4 | (6.5%) |
| 6 | 41 | (83.7%) | 8 | (16.3%) |
| 7 | 23 | (88.5%) | 3 | (11.5%) |
| 8 | 14 | (82.4%) | 3 | (17.6%) |
| 9 | 9 | (75.0%) | 3 | (25.0%) |
| 10 | 3 | (60.0%) | 2 | (40.0%) |
| 11 | 2 | (100.0%) | 0 | (0.0%) |
| 12 | 1 | (50.0%) | 1 | (50.0%) |
| Missing data | 40 | (90.9%) | 4 | (9.1%) |
| qSIRS | ||||
| 0 | 471 | (97.7%) | 11 | (2.3%) |
| 1 | 381 | (95.2%) | 19 | (4.7%) |
| 2 | 169 | (89.4%) | 20 | (10.6%) |
| 3 | 73 | (89.0%) | 9 | (11.0%) |
| 4 | 21 | (87.5%) | 3 | (12.5%) |
| 5 | 0 | (0.0%) | 1 | (100.0%) |
| Missing data | 67 | (89.3%) | 8 | (10.7%) |
| NSIRS | ||||
| 0 | 314 | (98.7%) | 4 | (1.3%) |
| 1 | 240 | (95.6%) | 11 | (4.4%) |
| 2 | 161 | (95.8%) | 7 | (4.2%) |
| 3 | 137 | (96.5%) | 5 | (3.5%) |
| 4 | 89 | (87.3%) | 13 | (12.7%) |
| 5 | 69 | (97.2%) | 2 | (2.8%) |
| 6 | 46 | (82.1%) | 10 | (17.9%) |
| 7 | 20 | (90.9%) | 2 | (9.1%) |
| 8 | 21 | (84.0%) | 4 | (16.0%) |
| 9 | 9 | (90.0%) | 1 | (10.0%) |
| 10 | 5 | (71.4%) | 2 | (28.6%) |
| 11 | 2 | (66.7%) | 1 | (33.3%) |
| 12 | 1 | (100.0%) | 0 | (0.0%) |
| 13 | 1 | (50.0%) | 1 | (50.0%) |
| Missing data | 67 | (89.3%) | 8 | (10.7%) |